Genprex GNPX
NASDAQ GNPX
$2.24 -0.05 (-2.18%)
As of: Nov 12, 2026 · 12:34 PM EST

Genprex (GNPX) Cost of Revenue (2024 - 2026)

Updated

Genprex's Cost of Revenue came in at $483,065 for Q1 2025, down 37.4% from $772,118 a year earlier.

Analysis

Genprex (GNPX) Cost of Revenue (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 3.93 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 8.10 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 4.29 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.89 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 2.95 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 2.79 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 1.57 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 4.03 Bn
10 Genprex 988,908.54 -41.15 Mn -423,306.00 423,306.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 423,306.00
Mar 31, 2026 612,212.00
Dec 31, 2025 114,570.00
Sep 30, 2025 188,532.00
Jun 30, 2025 472,598.00
Mar 31, 2025 483,065.00
Dec 31, 2024 548,985.00
Sep 30, 2024 589,548.00
Jun 30, 2024 252,279.00
Mar 31, 2024 772,118.00
API Access

Genprex Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=GNPX&period=max&api_key=YOUR_API_KEY